Close

Rating History for Affimed Therapeutics (AFMD) by Leerink Partners

More Stocks Rated by Leerink Partners | Latest Ratings for AFMD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/12/2022 Diana Graybosch Maintain Outperform
(N/A)		 6.00
(10.00)		  
 		   Details